Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts

Keshore R. Bidasee, Karuna Nallani, Bruce Henry, U. Deniz Dincer, Henry R. Besch

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

Alteration in cardiac function is one of the hallmarks of diabetes and in late stage is manifested as a decrease in contractility. While it is established that the release of calcium ions from internal sarcoplasmic reticulum via type 2 ryanodine receptor calcium-release channels (RyR2) is vital for efficient contraction, the relationship between diabetes-induced decrease in cardiac performance and alterations in expression and/or function of RyR2 is not well delineated. The present study was designed to address this question and to determine whether changes to RyR2 induced by chronic diabetes could be minimized with insulin-treatment. When paced at 3.3 Hz (200 beats per minute), hearts from 8-week streptozotocin-induced diabetic rats showed decreased responsiveness to isoproterenol stimulation; +dT/dt and -dT/dt were 56.5 ± 11.4% and 42.1 ± 12.1% that of control, respectively. Hearts from 8-week diabetic rats expressed 51.2% less RyR2 than controls. In addition, RyR2 from diabetic rats also showed decreased ability to bind the specific ligand [3H]ryanodine (22.4 ± 1.8% less [3H]ryanodine per μg of RyR2 protein), suggesting dysfunction. Two-weeks of insulin treatment, initiated after 6 weeks of untreated diabetes was able to minimize loss in function and expression of RyR2. Taken collectively, these data suggest that the decrease in cardiac contractility induced by chronic diabetes results in part from decreases in expression and alteration in function of RyR2 and these changes could be attenuated with insulin treatment.

Original languageEnglish (US)
Pages (from-to)113-123
Number of pages11
JournalMolecular and cellular biochemistry
Volume249
Issue number1-2
DOIs
StatePublished - Jul 1 2003

Fingerprint

Ryanodine Receptor Calcium Release Channel
Medical problems
Rats
Ryanodine
Insulin
Sarcoplasmic Reticulum
Streptozocin
Isoproterenol
Ions
Ligands
Calcium

Keywords

  • Binding affinity assays
  • Diabetes
  • Polyacrylamide gel electrophoresis
  • Reverse transcription-polymerase chain reaction
  • Streptozotocin
  • Type 2 ryanodine receptor

ASJC Scopus subject areas

  • Molecular Biology
  • Clinical Biochemistry
  • Cell Biology

Cite this

Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts. / Bidasee, Keshore R.; Nallani, Karuna; Henry, Bruce; Dincer, U. Deniz; Besch, Henry R.

In: Molecular and cellular biochemistry, Vol. 249, No. 1-2, 01.07.2003, p. 113-123.

Research output: Contribution to journalArticle

Bidasee, Keshore R. ; Nallani, Karuna ; Henry, Bruce ; Dincer, U. Deniz ; Besch, Henry R. / Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts. In: Molecular and cellular biochemistry. 2003 ; Vol. 249, No. 1-2. pp. 113-123.
@article{8369ec4337364d46aac349919c61f234,
title = "Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts",
abstract = "Alteration in cardiac function is one of the hallmarks of diabetes and in late stage is manifested as a decrease in contractility. While it is established that the release of calcium ions from internal sarcoplasmic reticulum via type 2 ryanodine receptor calcium-release channels (RyR2) is vital for efficient contraction, the relationship between diabetes-induced decrease in cardiac performance and alterations in expression and/or function of RyR2 is not well delineated. The present study was designed to address this question and to determine whether changes to RyR2 induced by chronic diabetes could be minimized with insulin-treatment. When paced at 3.3 Hz (200 beats per minute), hearts from 8-week streptozotocin-induced diabetic rats showed decreased responsiveness to isoproterenol stimulation; +dT/dt and -dT/dt were 56.5 ± 11.4{\%} and 42.1 ± 12.1{\%} that of control, respectively. Hearts from 8-week diabetic rats expressed 51.2{\%} less RyR2 than controls. In addition, RyR2 from diabetic rats also showed decreased ability to bind the specific ligand [3H]ryanodine (22.4 ± 1.8{\%} less [3H]ryanodine per μg of RyR2 protein), suggesting dysfunction. Two-weeks of insulin treatment, initiated after 6 weeks of untreated diabetes was able to minimize loss in function and expression of RyR2. Taken collectively, these data suggest that the decrease in cardiac contractility induced by chronic diabetes results in part from decreases in expression and alteration in function of RyR2 and these changes could be attenuated with insulin treatment.",
keywords = "Binding affinity assays, Diabetes, Polyacrylamide gel electrophoresis, Reverse transcription-polymerase chain reaction, Streptozotocin, Type 2 ryanodine receptor",
author = "Bidasee, {Keshore R.} and Karuna Nallani and Bruce Henry and Dincer, {U. Deniz} and Besch, {Henry R.}",
year = "2003",
month = "7",
day = "1",
doi = "10.1023/A:1024738706470",
language = "English (US)",
volume = "249",
pages = "113--123",
journal = "Molecular and Cellular Biochemistry",
issn = "0300-8177",
publisher = "Springer Netherlands",
number = "1-2",

}

TY - JOUR

T1 - Chronic diabetes alters function and expression of ryanodine receptor calcium-release channels in rat hearts

AU - Bidasee, Keshore R.

AU - Nallani, Karuna

AU - Henry, Bruce

AU - Dincer, U. Deniz

AU - Besch, Henry R.

PY - 2003/7/1

Y1 - 2003/7/1

N2 - Alteration in cardiac function is one of the hallmarks of diabetes and in late stage is manifested as a decrease in contractility. While it is established that the release of calcium ions from internal sarcoplasmic reticulum via type 2 ryanodine receptor calcium-release channels (RyR2) is vital for efficient contraction, the relationship between diabetes-induced decrease in cardiac performance and alterations in expression and/or function of RyR2 is not well delineated. The present study was designed to address this question and to determine whether changes to RyR2 induced by chronic diabetes could be minimized with insulin-treatment. When paced at 3.3 Hz (200 beats per minute), hearts from 8-week streptozotocin-induced diabetic rats showed decreased responsiveness to isoproterenol stimulation; +dT/dt and -dT/dt were 56.5 ± 11.4% and 42.1 ± 12.1% that of control, respectively. Hearts from 8-week diabetic rats expressed 51.2% less RyR2 than controls. In addition, RyR2 from diabetic rats also showed decreased ability to bind the specific ligand [3H]ryanodine (22.4 ± 1.8% less [3H]ryanodine per μg of RyR2 protein), suggesting dysfunction. Two-weeks of insulin treatment, initiated after 6 weeks of untreated diabetes was able to minimize loss in function and expression of RyR2. Taken collectively, these data suggest that the decrease in cardiac contractility induced by chronic diabetes results in part from decreases in expression and alteration in function of RyR2 and these changes could be attenuated with insulin treatment.

AB - Alteration in cardiac function is one of the hallmarks of diabetes and in late stage is manifested as a decrease in contractility. While it is established that the release of calcium ions from internal sarcoplasmic reticulum via type 2 ryanodine receptor calcium-release channels (RyR2) is vital for efficient contraction, the relationship between diabetes-induced decrease in cardiac performance and alterations in expression and/or function of RyR2 is not well delineated. The present study was designed to address this question and to determine whether changes to RyR2 induced by chronic diabetes could be minimized with insulin-treatment. When paced at 3.3 Hz (200 beats per minute), hearts from 8-week streptozotocin-induced diabetic rats showed decreased responsiveness to isoproterenol stimulation; +dT/dt and -dT/dt were 56.5 ± 11.4% and 42.1 ± 12.1% that of control, respectively. Hearts from 8-week diabetic rats expressed 51.2% less RyR2 than controls. In addition, RyR2 from diabetic rats also showed decreased ability to bind the specific ligand [3H]ryanodine (22.4 ± 1.8% less [3H]ryanodine per μg of RyR2 protein), suggesting dysfunction. Two-weeks of insulin treatment, initiated after 6 weeks of untreated diabetes was able to minimize loss in function and expression of RyR2. Taken collectively, these data suggest that the decrease in cardiac contractility induced by chronic diabetes results in part from decreases in expression and alteration in function of RyR2 and these changes could be attenuated with insulin treatment.

KW - Binding affinity assays

KW - Diabetes

KW - Polyacrylamide gel electrophoresis

KW - Reverse transcription-polymerase chain reaction

KW - Streptozotocin

KW - Type 2 ryanodine receptor

UR - http://www.scopus.com/inward/record.url?scp=0038330022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0038330022&partnerID=8YFLogxK

U2 - 10.1023/A:1024738706470

DO - 10.1023/A:1024738706470

M3 - Article

C2 - 12956406

AN - SCOPUS:0038330022

VL - 249

SP - 113

EP - 123

JO - Molecular and Cellular Biochemistry

JF - Molecular and Cellular Biochemistry

SN - 0300-8177

IS - 1-2

ER -